GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Techno Medica Co 6678.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,153

+1.22%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Techno Medica Co

Its shares trade on Tokyo Stock Exchange under the ticker 6678.T. It has been listed since 17 September 2003. In the fiscal year to 31 March 2026, it reported revenue of ¥11.24bn and net income of ¥1.07bn. At that date it held total assets of ¥17.97bn and shareholders' equity of ¥14.41bn.

Techno Medica Co., Ltd. engages in the manufacture and sale of analytical and medical equipment. The company is headquartered in Yokohama, Kanagawa-Ken. The company went IPO on 2003-09-17. The blood collection tube preparation apparatus business provides blood collection peripheral equipment, such as blood and urine collection automation reception equipment, among others, as well as blood tube preparation systems. The laboratory test apparatus business provides blood gas analysis apparatus, electrolyte analyzers, erythrocyte sedimetation rate measuring machines, among others. The consumable goods business provides blood collecting tubes, labels, sensor cards, calibration packs, among others, as well as maintenance services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
17 Sept 2003
Employees
225

Leadership

Pay as last reported

  • Mr. Masatomo SaneyoshiPresident, Chief Executive Officer, Representative Director, since 2009
  • Mr. Masato TakedaChief Director of Sales, Director of Main Office Sales, Director, since 2009
  • Mr. Kazuto TsugawaChief Director of Business Administration, Manager of Corporate Planning Office, Director, since 2018
  • Mr. Yasushi NakanoChief Director of Research and Development, Director of Medical Solution Development in Main Research and Development Unit, Director, since 2019
  • Mr. Shinichi MatsuoIndependent Director
  • Mr. Jun OzekiIndependent Director
  • Mr. Yousuke YasukataIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Company employs 225 full-time employees
  • Headquartered in Yokohama, Kanagawa-Ken
  • Offers three business segments: blood collection equipment, laboratory test apparatus, and consumable goods

Weaknesses

  • No specific financial data provided for analysis
  • No mention of market share or competitive positioning
  • No information on recent product innovations or R&D investments

Opportunities

  • Expansion of blood collection peripheral equipment market
  • Growth potential in laboratory test apparatus demand
  • Increased demand for consumable goods in healthcare sector

Threats

  • Dependence on a single industry sector (Health Care)
  • No information on global market presence beyond Japan
  • Potential regulatory changes affecting medical equipment industry

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.